Filters

CD181 antibody

CD181 antibody size: 0.025 miligrams 265

Supplier MBS MONO
Price 265
Size 0.025 miligrams
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Also known asCD181
Other namesN/A
CategoryAntibodies
SubcategoryMnoclonal antibodies
Gene nameCD181
Gene name synonimsN/A
Other gene namesN/A
ClonalityMonoclonal
Immunoglobulin isotypeIgG2b kappa
Clone8F1-1-4
Host organismMouse (Mus musculus)
Species reactivity Due to limited knowledge and inability for testing each and every species, the reactivity of the antibody may extend to other species which are not listed hereby, N/A
Specificity and cross-reactivity Since it is not possible to test each and every species our knowledge on the corss reactivity of the antibodies is limited, This particular antibody might cross react with speacies outside of the listed ones, Human
Purification methodCD181 antibody was purified by affinity chromatography
Form/Appearance may contain carrier protein/stabilizer, 09% sodium azide, Supplied in aqueous buffer with 0
Concentration500 ug/ml
Storage and shipping Keep the vial away from direct bright light, Variations in the range 1°, the antibody should NOT be frozen, C, C are tolerable, C to 9°, For short term storage keep the antibody at +4°
Tested applications: ELISA (EIA), Immunoprecipitation (IP), Flow Cytometry (FC)
French translationanticorps
Gene targetCD181
Short nameCD181 antibody
Alternative nameCD181 (Antibody to)
Alternative techniqueantibodies
Identity 6026
Gene CXCR1
Long gene name C-X-C motif chemokine receptor 1
Synonyms gene CMKAR1 IL8RA
Synonyms gene name alpha chemokine (C-X-C motif) receptor 1 , interleukin 8 receptor
Synonyms CKR-1 CDw128a CD181
Locus 2q35
Discovery year 1992-11-09
GenBank acession U11870
Entrez gene record 3577
Pubmed identfication 1303245 1427896
RefSeq identity NM_000634
Classification CD molecules C-X-C motif chemokine receptors Interleukin receptors
Havana BLAST/BLAT OTTHUMG00000133108

Similar products

Subscribe to our Newsletter